{
  "ptid_time": "011_S_4845_2012-07-12",
  "img_path": "/data/qiuhui/data/adni/images/011_S_4845/2012-07-12/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 49,333 mm³, 120.9% above the reference mean. With a Z-score of 3.02 (99.9th percentile), this represents profound enlargement; hippocampal volume measures 4,739 mm³, 38.3% below the reference mean. With a Z-score of -4.30 (0.0th percentile), this represents profound atrophy; whole brain volume measures 883,722 mm³, 14.1% below the reference mean. With a Z-score of -1.76 (3.9th percentile), this represents moderate atrophy; entorhinal cortex volume measures 2,711 mm³, 30.4% below the reference mean. With a Z-score of -2.35 (0.9th percentile), this represents significant atrophy; fusiform gyrus volume measures 15,034 mm³, 17.4% below the reference mean. With a Z-score of -1.96 (2.5th percentile), this represents moderate atrophy; middle temporal gyrus volume measures 12,715 mm³, 38.0% below the reference mean. With a Z-score of -3.38 (0.0th percentile), this represents profound atrophy. ",
  "text_data": "Age is 68.0 years. Gender is Female. Education: 20 years. Handedness: Right. Race: White. Medical history: Cardiovascular; Musculoskeletal; Major Surgical Procedures. MMSE: 22.0. MoCA: 11.0. Logical Memory: 0.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.31 SUVR (moderate elevated); Amyloid beta: 652.10 pg/mL (normal ); Total tau: 390.60 pg/mL (moderate elevated); Phosphorylated tau: 38.18 pg/mL (significant elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows profound hippocampal and middle temporal gyrus atrophy, along with significant ventricular enlargement and widespread cortical atrophy, consistent with advanced neurodegeneration. The cognitive scores (MMSE 22, MoCA 11) indicate significant impairment, while biomarkers (elevated T-tau, P-tau, and AV45) suggest Alzheimer's pathology despite normal Aβ.  \n\n**Diagnosis:** **Dementia (likely Alzheimer’s disease, atypical or late-stage due to normal Aβ but elevated tau and AV45)**  \n**Confidence:** **High** (due to severe atrophy, biomarker profile, and cognitive deficits, though Aβ-negative status warrants consideration of mixed pathology or tau-first variant).",
  "timestamp": "2025-07-25T23:00:07.197878"
}